Yi-bing Chen

469 total citations
9 papers, 382 citations indexed

About

Yi-bing Chen is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Yi-bing Chen has authored 9 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Yi-bing Chen's work include Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Cell Function and Interaction (3 papers). Yi-bing Chen is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immune Cell Function and Interaction (3 papers). Yi-bing Chen collaborates with scholars based in China, Hong Kong and Netherlands. Yi-bing Chen's co-authors include Jian‐Chuan Xia, Jing-Jing Zhao, Yong-Qiang Li, Ke Pan, Jia He, Shi-Ping Chen, Qi-Jing Wang, Miao-La Ke, Li-Xi Huang and Qiu-Zhong Pan and has published in prestigious journals such as PLoS ONE, World Journal of Gastroenterology and International Journal of Biological Sciences.

In The Last Decade

Yi-bing Chen

9 papers receiving 377 citations

Peers

Yi-bing Chen
Comparison fields: 5 of 45
  • Molecular Biology 197
  • Oncology 186
  • Immunology 151
  • Pathology and Forensic Medicine 94
  • Cancer Research 60
Replace Mai Ashizawa with:
Mai Ashizawa Japan
Yang Jiao China
Claudia Cippitelli Italy
Qinbo Cai China
Shengwei Mo China
Cristina Quero Spain
Nighat P. Khan India
Xiangyan Jiang China
Maria Vaysberg United States
Mohamed Abu Nada Qatar
Mai Ashizawa Japan View profile →
Citations per field, relative to Yi-bing Chen
Yi-bing Chen · 1×
Citations per year, relative to Yi-bing Chen
Yi-bing Chen · 1×

Countries citing papers authored by Yi-bing Chen

Since Specialization
Citations

This map shows the geographic impact of Yi-bing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-bing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-bing Chen more than expected).

Fields of papers citing papers by Yi-bing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi-bing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-bing Chen. The network helps show where Yi-bing Chen may publish in the future.

Co-authorship network of co-authors of Yi-bing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yi-bing Chen. A scholar is included among the top collaborators of Yi-bing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi-bing Chen. Yi-bing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
# Work Indexed citations
1 28
2 91
3 90
4 31
5 36
6 34
7 23
8 31
9 18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026